Creative Medical Technology Holdings, Inc. (CELZ)
NASDAQ: CELZ · Real-Time Price · USD
2.170
-0.100 (-4.41%)
Mar 31, 2025, 4:00 PM EDT - Market closed
CELZ Market Cap
CELZ has a market cap or net worth of $3.79 million as of March 31, 2025. Its market cap has decreased by -53.16% in one year.
Market Cap
3.79M
Enterprise Value
-1.96M
1-Year Change
-53.16%
Ranking
Category
Stock Price
$2.17
Market Cap Chart
Since December 11, 2017, CELZ's market cap has increased from $2.70M to $3.79M, an increase of 40.52%. That is a compound annual growth rate of 4.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 4.00M | - |
| Dec 31, 2024 | 4.00M | -37.50% |
| Dec 29, 2023 | 6.40M | 18.52% |
| Dec 30, 2022 | 5.40M | -66.46% |
| Dec 31, 2021 | 16.10M | 0.63% |
| Dec 31, 2020 | 16.00M | 2,185.71% |
| Dec 31, 2019 | 700.00K | -91.03% |
| Dec 31, 2018 | 7.80M | 457.14% |
| Dec 29, 2017 | 1.40M | -48.15% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |